Abbott Laboratories (ETR:ABL)

Abbott Laboratories Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 19, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	186,158	189,494	172,877	179,118	212,232	153,363
Market Cap Growth	-2.54%	9.61%	-3.48%	-15.60%	38.39%	12.04%
Enterprise Value	190,896	196,729	180,897	185,558	220,076	164,842
Last Close Price	107.18	107.36	95.48	97.44	116.03	81.04
PE Ratio	15.68	14.69	33.52	27.72	34.28	41.94
PS Ratio	4.98	4.68	4.76	4.39	5.60	5.42
PB Ratio	4.26	4.10	4.92	5.19	6.70	5.68
P/TBV Ratio	10.21	10.96	31.28	55.76	-	-
P/FCF Ratio	31.58	30.89	37.77	24.53	27.91	32.77
P/OCF Ratio	23.95	22.92	26.32	19.98	22.92	23.74
EV/Sales Ratio	5.10	4.86	4.99	4.54	5.81	5.83
EV/EBITDA Ratio	18.47	19.01	19.11	16.02	19.64	22.94
EV/EBIT Ratio	25.96	27.17	27.69	21.76	27.19	36.92
EV/FCF Ratio	32.38	32.07	39.52	25.41	28.94	35.23
Debt / Equity Ratio	0.25	0.32	0.41	0.49	0.53	0.60
Debt / EBITDA Ratio	1.07	1.38	1.48	1.41	1.47	2.18
Debt / FCF Ratio	1.88	2.41	3.16	2.30	2.23	3.48
Asset Turnover	0.55	0.54	0.54	0.58	0.58	0.49
Inventory Turnover	2.84	2.92	2.81	3.37	3.56	3.22
Quick Ratio	1.09	1.05	1.00	1.06	1.28	1.14
Current Ratio	1.70	1.67	1.64	1.63	1.85	1.72
Return on Equity (ROE)	30.62%	30.91%	15.11%	19.01%	20.49%	13.91%
Return on Assets (ROA)	6.79%	6.06%	6.11%	7.61%	7.79%	4.86%
Return on Capital (ROIC)	9.03%	7.94%	8.23%	10.34%	10.64%	6.61%
Return on Capital Employed (ROCE)	12.40%	11.10%	12.20%	15.50%	14.80%	9.00%
Earnings Yield	6.38%	6.83%	3.00%	3.62%	2.93%	2.40%
FCF Yield	3.17%	3.24%	2.65%	4.08%	3.58%	3.05%
Dividend Yield	1.97%	2.02%	1.97%	1.84%	1.38%	1.54%
Payout Ratio	28.93%	28.62%	62.13%	47.73%	45.28%	56.95%
Buyback Yield / Dilution	0.04%	0.06%	0.85%	1.40%	-0.17%	-0.28%
Total Shareholder Return	2.01%	2.07%	2.82%	3.24%	1.21%	1.26%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.